• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

    12/4/24 1:35:00 PM ET
    $FTII
    Blank Checks
    Finance
    Get the next $FTII alert in real time by email

    New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the "Company") (NASDAQ:FTII), today announced that it received an expected deficiency notification letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on November 27, 2024 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Q3 10-Q"), as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission (the "SEC") on November 15, 2024. The Staff also noted that this serves as an additional basis for delisting the Company's securities from Nasdaq and since the Company is already before a Hearings Panel for its failure to comply with the Market Value of Listed Securities requirement of Nasdaq Listing Rule 5420(a)(2) (the "Market Value of Listed Shares Rule"), the Company has until December 4, 2024 to request a stay of the sustention, pending a Hearings Panel decision. In addition, the Staff noted that based on the Company disclosure that 1,564,549 shares were tendered for redemption following the special meeting on November 18, 2024, the Company no longer complies with the minimum 1,100,000 publicly held shares requirement set forth in Listing Rule 5450(b)(2)(B) (the "Publicly Held Shares Rule").

    The Company has made progress towards regaining compliance. In particular, on November 27, 2024, the Company submitted a letter to Nasdaq setting forth the Company's plan to regain compliance with the Market Value of Listed Shares Rule. In addition, the Company has engaged an investment bank to assist with increasing the retail distribution of the Companies listed securities to obtain compliance with the Publicly Held Shares Rule and Market Value of Listed Shares Rule. With respect to filing Q3 10-Q, the Companies accountant and management are working toward filing it by December 13, 2024. The Company also requested the Staff to stay of suspension, pending a Hearings Panel decision and provide an exception to allow the Company to regain compliance with the Listing Rule 5250(c)(1), by filing the Q3 10-Q by December 13, 2024.

    About FutureTech II Acquisition Corp.

    FutureTech Capital Acquisition Corp. is a blank check company incorporated as a Delaware corporation for the purpose of effecting a business combination, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the U.S. Securities Exchange Act of 1934 ("Exchange Act") that are based on beliefs and assumptions and on information currently available to the Company. Forward-looking statements include all statements that are not historical facts and can generally be identified by terms such as "could," "would," "should," "estimate," "expect," "intend," "may," "plan," "potentially," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue," "ongoing," "target," "seek" or "will" or similar expressions and the negatives of those terms. These statements include, but are not limited to, statements relating to the Company's plans and expectations about the completion and filing of the Form 10-K, the Form 10-Q, its submission of a plan to regain compliance with respect to the Listing Rules of Nasdaq, and the timing thereof. Actual results could differ materially from those expressed in or implied by the forward-looking statements due to a number of risks and uncertainties, including but not limited to uncertainties about the timing of the Company's submission of a compliance plan, Nasdaq's acceptance of any such plan, and the duration of any extension that may be granted by Nasdaq; the potential inability to meet Nasdaq's requirements; uncertainties associated with the Company's preparation of the Form 10-K, form 10-Q and the related financial statements, including the possibility that additional accounting errors or corrections will be identified; the possibility of additional delays in the filing of the Form 10-K. the Form 10-Q and the Company's other SEC filings; and the other risks and uncertainties described in the Company's SEC reports. The forward-looking statements contained herein speak only as of the date of this press release. Except as required by law, the Company does not undertake any obligation to update or revise its forward-looking statements to reflect events or circumstances after the date of this press release.

    Investor Relations

    Ying Shan

    FutureTech Capital LLC

    [email protected]

    Media Relations

    Rathbun Communications

    Julie Rathbun

    [email protected]



    Get the next $FTII alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What was the reason for FutureTech II Acquisition Corp.'s deficiency notification from Nasdaq?

      FutureTech II Acquisition Corp. received a deficiency notification from Nasdaq on November 27, 2024 due to its failure to file the Q3 10-Q timely.

    • What is the current status of FutureTech II Acquisition Corp. regarding Nasdaq's listing rules?

      The company is already facing a Hearings Panel for failing to comply with Nasdaq's Market Value of Listed Shares Rule, leading to potential delisting.

    • What steps is FutureTech II Acquisition Corp. taking to regain compliance with Nasdaq listing rules?

      The company plans to file its Q3 10-Q by December 13, 2024, and has requested a stay of suspension from Nasdaq while awaiting a decision from the Hearings Panel.

    • How is FutureTech II Acquisition Corp. addressing its public shares requirement?

      The company has engaged an investment bank to enhance retail distribution of its listed securities to meet the Publicly Held Shares Rule and Market Value of Listed Shares Rule requirements.

    • What type of company is FutureTech II Acquisition Corp. and what is its primary purpose?

      FutureTech II Acquisition Corp. is classified as a blank check company, aimed at facilitating business combinations, share exchanges, or similar transactions.

    Recent Analyst Ratings for
    $FTII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FTII
    SEC Filings

    View All

    SEC Form 10-Q filed by FutureTech II Acquisition Corp.

    10-Q - FutureTech II Acquisition Corp. (0001889450) (Filer)

    8/22/25 5:10:57 PM ET
    $FTII
    Blank Checks
    Finance

    FutureTech II Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - FutureTech II Acquisition Corp. (0001889450) (Filer)

    8/18/25 5:26:57 PM ET
    $FTII
    Blank Checks
    Finance

    FutureTech II Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - FutureTech II Acquisition Corp. (0001889450) (Filer)

    8/15/25 6:41:34 PM ET
    $FTII
    Blank Checks
    Finance

    $FTII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

    New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the "Company") (NASDAQ:FTII), today announced that it received an expected deficiency notification letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on November 27, 2024 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Q3 10-Q"), as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission (the "SEC") on November 15, 2024. Th

    12/4/24 1:35:00 PM ET
    $FTII
    Blank Checks
    Finance

    Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

     -Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and services designed to increase the health span for the rapidly growing global aging population.    -Late-stage, diversified pipeline of therapeutic candidates across ophthalmology, cardiovascular disease and soft tissue reconstruction and repair.    -Near-term clinical milestones include Phase 3 start for LBI-201 for Ischemic stroke, Phase 2 data for LBI-101 for soft-tissue reconstruction, and Phase 2 start for LBI-001 in retinal vein occlusion.    -Seasoned management team of m

    9/20/24 2:55:00 PM ET
    $FTII
    Blank Checks
    Finance

    FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

    New Rochelle, NY, May 17, 2023 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (NASDAQ:FTIIU) (the "Company"), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, announced today that it caused to be deposited $1,150,000 into the Company's trust account for its public stockholders, representing $0.10 per public share, allowing the Company to extend by three months (from May 18, 2023 to August 18, 2023) the period of time the Company has to consummate its initial business combination (the "Extension"). The Extension is the second of two

    5/17/23 4:05:00 PM ET
    $FTII
    Blank Checks
    Finance

    $FTII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO & CFO Chen Ray Lei converted options into 380,000 shares (SEC Form 4)

    4 - FutureTech II Acquisition Corp. (0001889450) (Issuer)

    2/6/25 8:42:18 PM ET
    $FTII
    Blank Checks
    Finance

    Large owner Radu Zachary C. converted options into 2,445,000 shares (SEC Form 4)

    4 - FutureTech II Acquisition Corp. (0001889450) (Issuer)

    2/6/25 6:30:25 PM ET
    $FTII
    Blank Checks
    Finance

    Director Bush Neil converted options into 10,000 shares (SEC Form 4)

    4 - FutureTech II Acquisition Corp. (0001889450) (Issuer)

    2/6/25 4:48:44 PM ET
    $FTII
    Blank Checks
    Finance

    $FTII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

    SC 13G/A - FutureTech II Acquisition Corp. (0001889450) (Subject)

    11/14/24 1:07:48 PM ET
    $FTII
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

    SC 13G/A - FutureTech II Acquisition Corp. (0001889450) (Subject)

    11/13/24 4:51:36 PM ET
    $FTII
    Blank Checks
    Finance

    SEC Form SC 13G filed by FutureTech II Acquisition Corp.

    SC 13G - FutureTech II Acquisition Corp. (0001889450) (Subject)

    11/13/24 4:41:47 PM ET
    $FTII
    Blank Checks
    Finance